Many men might not even think to do it. But Color Genomics founder and president Othman Laraki has had himself tested for the BRCA pair of genes, which are widely known to correlate to breast cancer ...

BURLINGAME, Calif.--(BUSINESS WIRE)--With current genetic tests for breast and ovarian cancer risk costing up to $4,000 or more, Color Genomics today announced the immediate availability of the Color ...

Othman Laraki and Elad Gil were sitting on Twitter’s roof deck after their previous company Mixer Labs had been acquired. Gil had brought a small hard drive with him — which happened to contain data ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Color Genomics today announced a $45M investment led by General Catalyst with participation from Bono, singer-songwriter and philanthropist, and existing investors ...

Cancer and heart disease are the two leading causes of death in the United States. So far, Color Genomics has been focused on testing for mutations leading to a higher risk of certain cancers. But, ...

This week Color Genomics took the wraps off its first cardiovascular test for hereditary high cholesterol disorder —Familial Hypercholesterolemia (FH), a condition which increases the likelihood of ...

Color Genomics has been growing by leaps and bounds since launching its genetic spit test last year. Now, the company is adding $45 million in Series B funding to its coffers to keep the ball rolling.

Elad Gil, Color Genomics’ CEO, doesn’t believe that his company will make money by jacking up the price of its genetic tests. Just a decade ago, it cost thousands of dollars for women to get tested ...

At a recent event where he and his wife announced a $3 billion pledge intended to eradicate disease by the end of the century, Mark Zuckerberg noted a major inefficiency of the American health care ...

Color Genomics, a Burlingame, Calif.-based startup that has made a name for itself by selling tests for genes that dramatically raise the risk of cancer, is moving into a new area: heart disease. In ...

If you've ever wondered what your personal risk for developing breast cancer is, there's a new genetic test set to come out of Silicon Valley that could tell you exactly this. The test, which is being ...

For $249, Color Genomics wants to tell you if you have the genetic mutations that could predispose you to certain types of cancer. Color launched last April with its breast and ovarian cancer ...